Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy

NCT00001387 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: paclitaxel

Sponsor

National Cancer Institute (NCI)